Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) Among isolates from acrodermatitis chronica atrophicans lesions

Journal of Investigative Dermatology

Volumn 110, Issue 3, 1998, Pages 211-214

  Picken, Roger N ^a,c   Strle, Franc ^b,c   Picken, Maria M ^a   Ruzic Sabljic, Eva ^d   Maraspin, Vera ^b,c   Lotric Furlan, Stanka ^b,c   Cimperman, Joze ^b,c  

^a HINES VA HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Molecular characterization; Patient isolates

Indexed keywords

IMMUNOGLOBULIN G; RIBOSOME RNA;

ACRODERMATITIS CHRONICA ATROPHICANS; ADULT; AGED; ANTIBODY TITER; ARTICLE; BACTERIUM ISOLATION; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CLINICAL ARTICLE; DERMATITIS; FEMALE; HUMAN; HUMAN TISSUE; LYME DISEASE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT; SKIN BIOPSY;

BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII;

EID: 0031895272     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00130.x     Document Type: Article

References (26)

1. Abele DC, Anders KH: The many faces and phases of borreliosis H. J Am Acad Dermatol 23:401-410, 1990
2. Anthonissen FM, De Kesel M, Hoet PP, Bigaignon GH: Evidence for the involvement of different genospecies of Borrelia in the clinical outcome of Lyme disease in Belgium. Res Microbiol 145:327-331, 1994
3. Äsbrink E: Acrodermatitis chronica atrophicans. Clin Dermatol 11:.360-375, 1993
4. Äsbrink E, Hovmark A: Cutaneous manifestations in Ixodes-borne Borrelia spirochetosis. Int J Derm 26:215-223, 1987
5. Äsbrink E, Hovimark A: Early and late cutaneous manifestations in Ixodes-borne borreliosis (reythema migrans borreliosis, Lyme borreliosis) Ann NY Acad Sci 539:4-15, 1988
6. Äsbrink E, Hovmark A, Hederstedt B: The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol (Stockh) 64:506-512, 1984
7. Assous MV, Postic D, Paul G, Névot P, Baranton G: Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens, Eur J Clin Microbiol Infect Dis 12:261-268, 1993
8. Balmelli T, Piffaretti J-C: Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol 146:329-340, 1995
9. Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti JC, Assous M, Grimont PAD: Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov. & group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42:378-383, 1992
10. Belfaiza J, Postic D, Bellenger E, Baranton G, Saint Genomic I: Genomic fingerprinting of Borrelia burgdorferi sensu lato by pulsed-field gel electrophoresis. J Clin Microbiol 31:2873-2877, 1993
11. van Dam AP, Kuiper H, Vos K, et al: Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 17:708-717, 1993
12. Demaerschalk I, Messaoud AB, De Kesel M, et al: Simultaneous presence of different Borrclia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol 33:602-608, 1995
13. Edwards L, Hoshaw RA, Burgdorf WHC: Acrodermatitis chronica atrophicans. Arch Dermatol 128:858-860, 1992
14. Kaufman LD, Gruber BL, Philips ME, Benach JL: Late cutaneous Lyme disease: Acrodermatitis chronica atrophicans. Am J Med 86:828-830, 1989
15. Lavoie PE, Wilson AJ, Tuffanelli DL: Acrodermatitis chronica atrophicans with antecedent Lyme disease in California. Zentrlbl Baskteriel Mikrobiol Hyg [A] 263:262-265, 1986
16. Montgomery H, Sullivan R: Acrodermatitis chronica atrophicans. Arch Dermatol Syph 51:32-45, 1945
17. Ohlenbusch A, Matuschka F-R, Richter D, Christen H-J, Thomssen R, Spielman A, Eiffert H: Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis 174:421-423, 1996
18. Picken RN, Cheng Y, Han D, et al: Genotypic and phenotypic characterization of Borrelia burgdorferi isolated from ticks and small animals in Illiuois. J Clin Microbiol 33:2304-2315, 1995
19. Picken RN, Cheng Y, Strle F, et al: Molecular Characterization of Borrclia burgdorferi sensu lato from Slovenia Reveals Significant Differences Between Tick and Human Isolates. Eur J Clin Microbiol Infect Dis 15:313-323, 1996
20. Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A: Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis 154:295-300, 1986
21. Strle F, Cheng Y, Cimperman J, et al: Persistence of Borreila burgdorferi sensu lato in resolved erythema migrans lesions. Clin Infect Dis 21:380-389, 1995a
22. Strle F, Cheng Y, Nelson JA, Picken MM, Bouseman JK, Picken RN: Infection rate of Ixodes ricinus Ticks with Borrelia garinii, and Borrelia burgdorferi Sensu Stricto in Slovenia. Eur J Clin Microbiol Infect Dis 14:994-1001, 1995b
23. Tuffanelli D: Do some patients with morphea and lichen sclerosus et atrophicus have a Borrelia infection? Am J Dermatopathol 9:371-373, 1987
24. Wienecke R, Zöchling N, Neubert U, Schlüen E-M, Meurer M, Volkenandt M: Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J Invest Dermatol 103:19-22, 1995
25. Wilske B, Schierz B, Preac-Mursic V, Weber K, Pfister HW, Einhaupl KM: Serological diagnosis in erythema migrans disease and related disorders. Infection 12:331-337, 1984
26. Wilske B, Preac-Mursic V, Göbel UB, et al: An OspA serotyping system for Borreila burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J Clin Microbiol 31:340-350, 1993